What is a stock summary page? Click here for an overview.
Business Description
Medicamen Biotech Ltd
ISIN : INE646B01010
Share Class Description:
BOM:531146: Shs DematerialisedCompare
Compare
Traded in other countries / regions
531146.India IPO Date
2000-08-29Description
Medicamen Biotech Ltd is an Indian based pharmaceutical company. The company is engaged in developing and manufacturing Pharmaceuticals formulations products. It manufactures Tablets, Capsules, Oral liquids, Dry syrups, Ointments, and Oral rehydration solution. The company generates revenue from the sale of pharmaceutical products.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.32 | |||||
| Equity-to-Asset | 0.75 | |||||
| Debt-to-Equity | 0.09 | |||||
| Debt-to-EBITDA | 0.89 | |||||
| Interest Coverage | 2.93 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 5.7 | |||||
| Beneish M-Score | -1.88 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 15.4 | |||||
| 3-Year EBITDA Growth Rate | 5.9 | |||||
| 3-Year EPS without NRI Growth Rate | -4.7 | |||||
| 3-Year FCF Growth Rate | -34.3 | |||||
| 3-Year Book Growth Rate | 14.4 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 40.4 | |||||
| 9-Day RSI | 43.74 | |||||
| 14-Day RSI | 44.81 | |||||
| 3-1 Month Momentum % | 7.13 | |||||
| 6-1 Month Momentum % | 0.6 | |||||
| 12-1 Month Momentum % | 35.17 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.28 | |||||
| Quick Ratio | 1.41 | |||||
| Cash Ratio | 0.09 | |||||
| Days Inventory | 226.22 | |||||
| Days Sales Outstanding | 126.03 | |||||
| Days Payable | 177.15 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.22 | |||||
| Dividend Payout Ratio | 0.15 | |||||
| 3-Year Dividend Growth Rate | 26 | |||||
| Forward Dividend Yield % | 0.22 | |||||
| 5-Year Yield-on-Cost % | 0.22 | |||||
| 3-Year Average Share Buyback Ratio | -1.3 | |||||
| Shareholder Yield % | 0.54 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 47.6 | |||||
| Operating Margin % | 7.13 | |||||
| Net Margin % | 5.11 | |||||
| FCF Margin % | -7.23 | |||||
| ROE % | 4.43 | |||||
| ROA % | 3.14 | |||||
| ROIC % | 3.67 | |||||
| 3-Year ROIIC % | -2.01 | |||||
| ROC (Joel Greenblatt) % | 7.93 | |||||
| ROCE % | 6.84 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 67.13 | |||||
| PE Ratio without NRI | 67.55 | |||||
| Shiller PE Ratio | 41.2 | |||||
| PEG Ratio | 18.26 | |||||
| PS Ratio | 3.21 | |||||
| PB Ratio | 2.71 | |||||
| Price-to-Tangible-Book | 2.6 | |||||
| EV-to-EBIT | 39.71 | |||||
| EV-to-EBITDA | 25.16 | |||||
| EV-to-Revenue | 3.17 | |||||
| EV-to-FCF | -43.26 | |||||
| Price-to-GF-Value | 0.5 | |||||
| Price-to-Projected-FCF | 12.08 | |||||
| Price-to-DCF (Earnings Based) | 6.54 | |||||
| Price-to-Median-PS-Value | 0.67 | |||||
| Price-to-Graham-Number | 2.9 | |||||
| Price-to-Net-Current-Asset-Value | 6.65 | |||||
| Earnings Yield (Greenblatt) % | 2.5 | |||||
| FCF Yield % | -2.34 | |||||
| Forward Rate of Return (Yacktman) % | 1.39 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medicamen Biotech Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 1,802.537 | ||
| EPS (TTM) (₹) | 6.808 | ||
| Beta | 0.61 | ||
| 3-Year Sharpe Ratio | -0.03 | ||
| 3-Year Sortino Ratio | -0.05 | ||
| Volatility % | 78.06 | ||
| 14-Day RSI | 44.81 | ||
| 14-Day ATR (₹) | 32.628353 | ||
| 20-Day SMA (₹) | 465.8225 | ||
| 12-1 Month Momentum % | 35.17 | ||
| 52-Week Range (₹) | 377 - 630 | ||
| Shares Outstanding (Mil) | 12.71 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medicamen Biotech Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medicamen Biotech Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Medicamen Biotech Ltd Frequently Asked Questions
What is Medicamen Biotech Ltd(BOM:531146)'s stock price today?
The current price of BOM:531146 is ₹440.30. The 52 week high of BOM:531146 is ₹630.00 and 52 week low is ₹377.00.
When is next earnings date of Medicamen Biotech Ltd(BOM:531146)?
The next earnings date of Medicamen Biotech Ltd(BOM:531146) is .
Does Medicamen Biotech Ltd(BOM:531146) pay dividends? If so, how much?
The Dividend Yield %  of Medicamen Biotech Ltd(BOM:531146) is 0.22% (As of Today), Highest Dividend Payout Ratio of Medicamen Biotech Ltd(BOM:531146) was 0.15. The lowest was 0.05. And the median was 0.09. The  Forward Dividend Yield % of Medicamen Biotech Ltd(BOM:531146) is 0.22%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers